Clinical Trial Update: Use of Platelet-Rich Fibrin (PRF) in the Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) [NA]

View source ↗

Summary

A completed clinical trial evaluating the use of Platelet-Rich Fibrin (PRF) to manage medication-related osteonecrosis of the jaw.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medication-related Osteonecrosis of the Jaw

Drugs mentioned

• Platelet Rich Fibrin (platelet-rich fibrin)

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: Medication Related Osteonecrosis of the Jaw | NA | Status: COMPLETED